Exponent : An Introduction to the EU Biocidal Products Regulation
April 23, 2018 at 08:12 pm EDT
Share
Exponent staff David Dillon, Senior Managing Scientist, Regulatory (Biocides) and Dr. Karen Howard, Principal Scientist, Regulatory (Biocides) will be speaking at the Biocidal Product Regulation Conference, April 25-26, 2018 in London, England. They will offer in-depth insights into the background and practical implications of the EU Biocides Regulation (EU) No 528/2012.
This new two-day training course from BiocidesHub has been designed to offer a comprehensive introduction to the Biocidal Products Regulation (EU) No. 528/2012 - from the different biocidal product types and approval of active substances to risk assessment and product labelling.
For more information please see the event website.
Attachments
Original document
Permalink
Disclaimer
Exponent Inc. published this content on 25 April 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 24 April 2018 00:11:02 UTC
Exponent, Inc., together with its subsidiaries, is a science and engineering consulting firm. The Company serves clients in chemicals, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors. It provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project- by-project basis. The Company has two segments: Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment is a service group providing technical consulting in different practices, primarily in engineering. The Environmental and Health segment provides services in the area of environmental, epidemiology and health risk analysis. This segment provides a range of consulting services relating to environmental hazards and risks and the impact on both human health and the environment.
EXPONENT, INC. 
